Delivery Order SPE2DE21D0007-SPE2D624F9C79
- Not listed
- The U.S. government's Defense Logistics Agency Troop Support Medical awarded a $1,832.54 fixed price delivery order contract to Ortho-Clinical Diagnostics, Inc. for the purchase of 4564336504 ANTI-A BIOCLONE 15X10ML medical supplies. The contract has an ultimate completion date of May 10, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit medical equipment manufacturer that provides a range of diagnostic solutions to federal agencies, including the Department of Veterans Affairs and...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The $1,832.54 fixed price with economic price adjustment delivery order is for the procurement of ANTI-B BIOCLONE 15X10ML medical supplies. The award is not associated with a set-aside program. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and testing services to...
- This federal contract award, valued at $2,072.88, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc. for the delivery of ANTI-A BIOCLONE 15X10ML medical supplies. The contract was awarded as a fixed price with economic price adjustment delivery order, without any set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including reagents, test kits, and clinical...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
- This $1,389.05 fixed price with economic price adjustment delivery order contract was awarded by the Medical Supply Chain agency, which is part of the Defense agency, to Ortho-Clinical Diagnostics, Inc. The contract is for the supply of 4566739666 - ANTI-A BIOCLONE 15X10ML, with a completion date of December 19, 2024. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides diagnostic solutions and has delivered products to various federal agencies including the Department of...
- This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the delivery of 4567190755 ANTI-B BIOCLONE 15X10ML, a critical medical diagnostic product. It is a fixed price delivery order with economic price adjustment, with a completion date of February 12, 2025. No set-aside designation was used, indicating open competition....
- This is a $1,389.05 fixed price with economic price adjustment delivery order awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc. for anti-A bioclone medical supplies. The award is not associated with a set-aside and has a completion date of January 13, 2025. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has provided a range of diagnostic solutions, reagents, and services to federal agencies including the Department...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,037.23 firm fixed price delivery order is for the supply of 4566514555 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The ultimate completion date for this contract is November 26, 2024. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and testing services to federal agencies...
- This federal contract award with the ID SPE2DE21D0007|SPE2D624F2NUC was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc. for the delivery of 4565883575 ANTI-B BIOCLONE 15X10ML. The $1,832.54 fixed-price with economic price adjustment contract has an ultimate completion date of September 24, 2024. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides diagnostic solutions to various federal agencies,...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- SPE2DE21D0007Indefinite Delivery Contract
- SPE2DE21D0007-SPE2D624F9C79Delivery Order
This federal contract award was issued by the Defense Health Agency, a component of the Department of Defense, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,767.32 fixed-price delivery order is for 4564226230 - ANTI-A,B BIOCLONE 15X10ML, with a period of performance through April 11, 2024. Ortho-Clinical Diagnostics has provided various medical equipment, reagents, and testing services to federal agencies, including the Department of Veterans Affairs, under both competitive and sole-source contracts. The award does not have a set-aside designation. Ortho-Clinical Diagnostics holds several indefinite-delivery/indefinite-quantity contracts and blanket purchase agreements with agencies like the Veterans Health Administration and Defense Health Agency to supply critical diagnostic equipment, reagents, and related services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/8/24 |